Group items tagged

Ophthalmology is a branch of science that deals with the diagnosis and treatment of ophthalmic (eye) disorders. Optometry equipment are used to monitor, diagnose, and prevent ophthalmic disorders such as glaucoma and cataract. They include a set of equipment used for retina and glaucoma examination, cornea and cataract examination, as well as for general examination. These equipment include wavefront aberrometers, specular microscopes, ophthalmoscopes, autorefractors and keratometers, fundus cameras, visual field analyzers, retinoscopes, and among others. Cataract surgery is one of the most common surgical procedures performed in Germany, where around 700,000 people undergo cataract surgery every year. Cataract surgery is a procedure to replace the lens of the eye with an artificial one. Whereas, glaucoma is one of the leading cause of irreversible blindness worldwide. In Mexico, around 854,000 people have glaucoma in their eyes. Moreover, the phoropter is one of the basic equipment used by optometrists to measure the refractive error and determine the patient's eyeglass numbers. Optometry equipment are designed to prevent potential eye damage, disease, or injuries. Read More @ https://coherentmarketinsights-cmi.blogspot.com/2020/11/simple-guide-to-most-common-optometry.html

The growing incidence of viral conjunctivitis cases is driving the growth of the viral conjunctivitis drugs market. According to National Center for Biotechnology: 2017, adenovirus is the most common cause of viral conjunctivitis and up to 70% of cases of acute conjunctivitis are viral. The number of individuals affected by viral conjunctivitis is estimated to be as high as 15 to 20 million per year in the U.S. Additionally, a rising number of research and development activities for enhancing the effectiveness of viral conjunctivitis drugs is again projected to accelerate the growth of the market. For instance, in 2019, iVIEW Therapeutics Inc., a clinical-stage ophthalmology drug development company, announced the dosing of the first patient in Phase II clinical trial. iVIEW Therapeutics Inc. is testing the safety and efficacy of the IVIEW-1201 in patients (age ≥15 years) for the treatment of acute adenoviral conjunctivitis. In 2018, Starpharma Holdings Limited, a company headquartered in Australia, received a patent for SPL7013 ophthalmic drops for viral conjunctivitis from the U.S. Patent and Trademark Office. The patent has been granted to the company due to its broad claims for treating and preventing microbial infections of the eye, including adenoviral conjunctivitis, bacterial conjunctivitis, and other eye infections. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/08/starpharma-holdings-limited-received.html

THRISSUR: Besides creating nuisance to those around you, snoring can aggravate glaucoma-optic nerve damage associated with the buildup of pressure in the eye-leading to loss of vision, experts said. Studies reinforced the belief that those who snore were at the risk of developing glaucoma, ophthalmic surgeon Dr Rani Menon said.

Europe Blow Fill Seal Technology market is anticipated to grow appreciably at rate in the forecasted period. This is attributed to the rising demand for personalized medicine, increasing focus towards consumer protection, and growing adoption of Blow Fill Seal Technology (BFS) technology in the pharmaceutical industry. Blow Fill Seal (BFS) technology is a manufacturing process used in the pharmaceutical and healthcare industries to produce small, sterile, and sealed containers for liquid or semi-solid products. It is a highly automated and efficient process that integrates container formation, filling, and sealing into a single continuous operation. Blow Fill Seal (BFS) technology is commonly used for the production of unit-dose containers for ophthalmic solutions, respiratory drugs, sterile injectables, nasal sprays, and other liquid or semi-solid pharmaceutical products.